Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 1/20 | 0.53 |
| ▸ | PPARG | P37231 | 1/20 | 0.44 |
| ▸ | PPARA | Q07869 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | GNRHR | P30968 | 4/20 | 0.42 |
| ▸ | FAAH | O00519 | 3/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | BMP1 | P13497 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | DHODH | Q02127 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4766751 | 0.95 | C5AR1 (0.58) | C5AR1PPARGPPARATSHRFAAH | |
| SCHEMBL5137315 | 0.91 | C5AR1 (0.51) | C5AR1PPARGPPARATSHRFAAH | |
| SCHEMBL5136961 | 0.91 | C5AR1 (0.53) | C5AR1PPARGPPARATSHRFAAH | |
| SCHEMBL5136938 | 0.89 | C5AR1 (0.66) | C5AR1PPARGPPARATSHRGNRHR | |
| SCHEMBL4768447 | 0.88 | C5AR1 (0.64) | C5AR1PPARGPPARATSHRGNRHR | |
| SCHEMBL5136860 | 0.88 | C5AR1 (0.55) | C5AR1PPARGPPARATSHRGNRHR | |
| SCHEMBL5135513 | 0.88 | C5AR1 (0.58) | C5AR1PPARGPPARATSHRGNRHR | |
| SCHEMBL648484 | 0.86 | C5AR1 (0.56) | C5AR1PPARGPPARATSHRGNRHR | |
| SCHEMBL5135228 | 0.85 | C5AR1 (0.58) | C5AR1PPARGPPARATSHRFAAH | |
| SCHEMBL5134492 | 0.85 | GAA (0.44) | FAAHKMT2AGAADHODHALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490044-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORP (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1490044-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003084524-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |